Compal, a major contract manufacturer, is further expanding its smart healthcare initiatives. On March 29th, Chun-de Shen, Chief Technology Officer and Senior Vice President, announced that the group's cardiovascular imaging medical devices and dementia AI EEG analyzers are expected to receive certification from the Taiwan Food and Drug Administration (TFDA) in the second quarter and by the end of the year, respectively.
Read more
